Trial Profile
Efficacy of Ripasudil as a second line medication in patients with Exfoliation Glaucoma:A retrospective, pilot, cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2017
Price :
$35
*
At a glance
- Drugs Ripasudil (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 08 Apr 2017 New trial record
- 27 Mar 2017 Results published in the Clinical Drug Investigation